biote Corp. BTMD

1.22 (0.01) (0.81%) as of 25 Sep
Market cap
$44.2M
P/E
7.8×
Insider Buys alert about insiders buying in the last 12 month
Dec '17 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— — 0.00 0.26 0.00 29.43 3.02
P/S ratio
— — 0.00 0.18 0.66 1.07 0.42
P/FCF ratio
— — 2.58 0.00 5.03 5.53 2.87
P/Operating CF
— — 7.64 4.81 17.48 17.12 10.75
P/B ratio
— — 18.68 0.00 0.00 0.00 0.00
Price to Tangible BV
— — 18.68 0.00 0.00 0.00 0.00
EV/Sales
— — 0.00 0.41 0.78 1.42 0.85
EV/EBITDA
— — 2.46 0.00 4.48 7.77 4.10
EV/Operating CF
— — 2.59 (7.45) 5.41 6.19 4.67
EV/FCF
— — 2.92 (6.20) 6.02 7.31 5.80
Quick Ratio
— 0.01 1.85 4.59 4.31 0.91 0.69
Current Ratio
— 0.01 2.72 5.39 5.51 1.32 1.22
Net Debt/EBITDA
— 0.00 0.28 (0.67) 0.74 1.89 2.07
Debt/Assets
0.00% 0.00% 68.03% 105.99% 72.69% 87.81% 99.46%
Debt/Equity
— 0.00 8.96 (2.03) (3.09) (1.05) (2.12)
Asset Turnover
— 0.00 5.12 1.99 1.39 1.42 1.67
Operating CF/Net income
— 0.00 1.03 9.45 8.11 14.33 1.30
Capex/Depreciation
— — (2.35) (0.66) (0.72) (1.58) (1.52)
Interest Coverage
— — 0.00 0.00 0.00 0.00 0.00
ROE
— 0.00% 1,572.00% 3.58% (6.99%) (4.55%) (35.45%)
ROA
— 0.00% 119.75% (1.17%) 2.48% 2.27% 23.52%
ROIC
— 0.00% 150.82% 0.00% 0.00% 0.00% 68.34%
Return on Tangible Assets
— 0.00% 101.59% (1.15%) 3.27% 13.39% 132.37%
Average Days of Receivables
— — 13.70 15.37 13.41 14.13 13.04
Research and Development Expense of Revenue
— — 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
— — 38.71% 103.73% 53.32% 54.49% 52.97%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.05 0.00 0.09 0.09
Share Based Compensation of Revenue
— — 0.00% 49.82% 4.89% 4.43% 4.64%
Graham Net Nets
— — (0.04) (2.36) (0.57) (0.74) (1.27)
Graham Number
— — 0.00 0.00 2.26 0.00 0.00
Earnings Yield
— — (1.40%) 378.39% (3.38%) 3.40% 33.08%
Free Cash Flow Yield
— — 38.83% (37.79%) 19.88% 18.08% 34.83%
Revenue per Share
— 0.00 18.40 20.47 7.21 5.75 6.14
Operating CF per Share
— 0.00 4.45 (1.14) 1.05 1.32 1.13
Capex per Share
— 0.00 (0.50) (0.23) (0.11) (0.20) (0.22)
Free Cash Flow per Share
— 0.00 3.95 (1.36) 0.94 1.12 0.91
Cash per Share
— 0.00 3.53 9.83 3.46 1.15 0.77
Shareholders Equity per Share
— 0.00 0.54 (7.23) (1.42) (2.98) (1.61)
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— 0.00 0.54 (7.23) (1.42) (2.98) (1.61)
Free Cash Flow
— 0.00 29.91 (10.99) 24.17 38.29 28.33
Working Capital
— (0.12) 29.77 82.41 100.13 16.61 9.68
Capital Expenditures
— — (3.81) (1.84) (2.71) (6.96) (6.86)
Net Current Asset Value
— (0.12) (3.12) (68.74) (69.50) (156.44) (103.34)
EV/EBIT
— — 2.52 0.00 5.08 8.85 4.62
Capex to Sales
— — 0.03 0.01 0.01 0.04 0.04
Net Profit Margin
— — 23.40% (0.59%) 1.79% 1.60% 14.07%
Price to Operating Income
— — 2.23 0.00 4.24 6.70 2.29
Other line items
Depreciation/Fixed assets
— — 0.69 1.85 3.11 0.63 0.42
Cash ROIC
— 0.00% 46.25% (7.65%) 15.52% 85.82% 30.26%
Accounts Receivable Turnover
— — 0.00 27.09 26.95 27.31 26.51
Accounts Payable Turnover
— — 0.00 12.90 14.00 11.66 8.68
Inventory Turnover
— — 0.00 5.25 4.06 3.62 3.24
Average Days of Payables
— — 32.52 27.50 26.20 36.50 45.42
Days of Inventory on Hand
— — 71.89 74.79 109.15 93.21 126.84
Average Receivables
— — — 6.09 6.88 7.22 7.25
Average Payables
— — — 4.23 4.13 4.98 6.32
Average Inventory
— — — 10.40 14.25 16.08 16.95
Average Assets
— 0.07 27.24 82.99 133.47 138.83 114.99
Average Common Equity
— (11.30) 2.08 (27.07) (47.41) (69.37) (76.30)

Fold the line items

Columns are period end dates